All
Fire Needle Combined With Excimer Laser Safe, Effective Therapy for Vitiligo, Review Finds
Combining fire needle therapy with a 308 nm excimer laser for vitiligo treatment, as per a recent meta-analysis, was deemed both safe and effective.
MoonLake Immunotherapeutics and Komodo Health to Partner to Improve Research on Inflammatory Skin Conditions
MoonLake’s sonelokimab is being evaluated for hidradenitis suppurativa, psoriasis, and psoriatic arthritis.
Allergan Aesthetics Launches 2 Products For Acne-Prone Skin
Mona Gohara, MD, explained the importance of the products' impact on the skin barrier.
CP-GEP Model Successful in Stratifying Node-Negative Patients into Risk Groups for Melanoma Disease Progression
According to 2 studies, this model has demonstrated the potential to assist in developing treatment and monitoring plans for early-stage melanomas.
Apremilast Demonstrates Consistent Safety and Efficacy in Children with Moderate to Severe Plaque Psoriasis at 52 Weeks
Loretta Fiorillo, MD, FRCPC, reviews key data points from the phase 3 SPROUT study.
Meet the Spring Editor in Chief: Aaron Farberg, MD
Dermatology Times is pleased to introduce our Spring Editor in Chief, Aaron Farberg, MD, with a snapshot of his involvement in the dermatology space.
Rosacea Awareness Month: Resources to Share With Your Patients
This Rosacea Awareness Month, we have compiled a list of resources for clinicians to share with their rosacea patients.
Journal Digest: April 8
This week’s collection of the latest dermatologic studies covers circulating tumor DNA in advanced cSCC, targeting IL-13 with tralokinumab in AD, a pediatric lymphoplasmocytic plaque case report, and skin of color reporting in randomized controlled trials focusing on SCC.
Springing Into the Latest Research in Dermatology
In an introduction to our April publication, explore an overview of topics covered in this issue and an introduction to our Spring Editor in Chief, Aaron Farberg, MD.
Phase 1b Data for Topical Pravibismane in Diabetic Foot Ulcer Infection Demonstrates Favorable Effects and Safety
Data was recently published in the International Wound Journal supporting positive outcomes in moderate or severe ulcers.
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Christopher Bunick, MD, PhD, delves into current data and guidelines to consider when creating custom treatment plans for patients with atopic dermatitis.
QUIZ: Test Your Knowledge of Rosacea Etiology, Types, and Triggers
Click here to read more and answer our quiz questions in recognition of Rosacea Awareness Month.
Derm In The News: March 31-April 6
Keep up with the latest headlines in dermatology from the past week, including the launch of an expanded job board for dermatology support roles, CMS and Incyte's collaboration for povorcitinib in China and Southeast Asia, and more.
The Weekly Roundup: April 1-5
ICYMI, this week we had news about Ycanth's J-code launch, highlights from Diversity in Dermatology, bimekizumab's accepted sBLA for HS, and more.
Increased Levels of B-Type Natriuretic Peptide May be Associated With Various Types of Chronic Itch
Gil Yosipovitch, MD, discusses the correlation between increased BNP levels and chronic pruritus of unknown origin.
Countdown to RAVE!
Three distinct congresses known as RAVE (Revolutionizing Atopic Dermatitis, Alopecia Areata, and Vitiligo) will be held June 8-10, in Chicago, Illinois.
Topical Permethrin Demonstrates Lack of Efficacy Compared to Benzyl Benzoate in Most Scabies Cases
In a comparative study, benzyl benzoate demonstrated superior efficacy in scabies cases, while topical permethrin exhibited a lack of effectiveness.
Omalizumab for Chronic Spontaneous Urticaria Does Not Yield Negative Maternal, Fetal Outcomes in Pregnancy
Researchers reviewed the efficacy and safety of omalizumab in patients with severe CSU in a routine clinical practice setting.
Managing Mental Health Comorbidities in Adult Patients With Atopic Dermatitis
Researchers address the persisting gaps in managing mental health comorbidities within the framework of existing clinical practice guidelines.
Be Proactive When Combatting Tanning Bed Misinformation on Social Media
Influencers promote the use of tanning beds and list the “benefits,” such as obtaining vitamin D and helping with seasonal affective disorder, among other reasons that have no merit.
Journal Digest: April 4
This week’s collection of the latest dermatologic studies covers topical permethrin 5% vs. benzyl benzoate 25% for scabies, the safety of omalizumab in CSU during pregnancy, symptoms of cognitive impairment in children with AD, and the ethics of cosmetic overtreatment.
Botulinum Toxin, Dermal Fillers Generally Effective and Well-Tolerated in Skin of Color Populations
In a literature review, researchers found data supporting the efficacy and safety of fillers in patients with skin of color, particularly for populations where is there is limited data.
Topical Melatonin and Rosuvastatin Reduce Severity of Mild to Moderate Plaque Psoriasis
Versus placebo, topical melatonin and rosuvastatin reduced psoriatic plaque severity with a favorable safety profile.
FDA Accepts Supplemental Biologics License Applications for Bimekizumab to Treat HS
The submission stems from promising results from the phase 3 BE HEARD I and BE HEARD II trials.
Dupilumab Shows Superiority in Reducing Upper Respiratory Infections in Patients With AD
The risk of upper respiratory infection-related mortality was notably diminished in the study's dupilumab cohort.
Elevated Plasma Calcitonin Gene-Related Peptide Levels in Patients With Rosacea May Open Door for New Therapeutic Approaches
One study uncovered high levels of CGRP in patients with rosacea, with levels not affected by age, sex, BMI, and other factors.
New Data on Retinol: Patricia Farris, MD, Shares Insights on Anti-Aging
In this study, topical 0.1% retinol significantly improved crow’s feet, facial wrinkles, uneven skin tone, brown spots, and overall photoaging.
Pointers With Portela: Effects of Hormone Changes on the Skin
In this week’s Pointers With Portela, the 208SkinDoc reviews how the skin is affected during hormonal changes and menopause.
Pelthos Therapeutics Launches to Accelerate Commercialization of Treatment for Molluscum Contagiosum
The new launch is set to bring berdazimer topical gel, 10.3% to adults and pediatric patients over the age of 1 with molluscum contagiosum faster.
ARCA Biopharma and Oruka Therapeutics Agree to Merger
The merger will focus on advancing Oruka’s portfolio of novel biologics for the treatment of chronic skin diseases.